Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;8(Suppl 4):S395-S399.
doi: 10.21037/tlcr.2019.08.24.

For a better adjuvant strategy for resected lung cancer-lessons from treatment failure patterns of the ADJUVANT trial (CTONG 1104)

Kenichi Suda  1
Affiliations
Editorial

For a better adjuvant strategy for resected lung cancer-lessons from treatment failure patterns of the ADJUVANT trial (CTONG 1104)

Kenichi Suda. Transl Lung Cancer Res. 2019 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has received honoraria from Boehringer Ingelheim, has served as an advisory board member for AstraZeneca, and has received research funding (through Kindai University Faculty of Medicine) from Boehringer Ingelheim and Rain Therapeutics.

Figures

Figure 1
Figure 1
Estimated curves for hazard rate of treatment failure in patients who have undergone surgical resection of lung cancer. (A) Hazard curve in patients who did not receive adjuvant therapy. The curve is original which was generated by the author referring to previous studies (14,15); (B) hazard curve in patients who received adjuvant VP chemotherapy; (C) hazard curve in patients who received adjuvant gefitinib monotherapy. VP, vinorelbine plus cisplatin; EGFR, epidermal growth factor receptor; TKI, tyrosine kinase inhibitor.
See this image and copyright information in PMC

Comment on

References

    1. Okami J, Shintani Y, Okumura M, et al. Demographics, safety and quality, and prognostic information in both the seventh and eighth editions of the TNM classification in 18,973 surgical cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010. J Thorac Oncol 2019;14:212-22. - PubMed
    1. Suzuki K, Saji H, Aokage K, et al. Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial. J Thorac Cardiovasc Surg 2019;158:895-907. 10.1016/j.jtcvs.2019.03.090 - DOI - PubMed
    1. Nelson DB, Mehran RJ, Mitchell KG, et al. Robotic-assisted lobectomy for non-small cell lung cancer: a comprehensive institutional experience. Ann Thorac Surg 2019;108:370-6. 10.1016/j.athoracsur.2019.03.051 - DOI - PubMed
    1. Bertolaccini L, Batirel H, Brunelli A, et al. Uniportal video-assisted thoracic surgery lobectomy: a consensus report from the Uniportal VATS Interest Group (UVIG) of the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg 2019;56:224-9. 10.1093/ejcts/ezz133 - DOI - PubMed
    1. Kenmotsu H, Ohde Y, Wakuda K, et al. Survival data for postoperative adjuvant chemotherapy comprising cisplatin plus vinorelbine after complete resection of non-small cell lung cancer. Cancer Chemother Pharmacol 2017;80:609-14. 10.1007/s00280-017-3400-z - DOI - PubMed